Gritstone bio Inc GRTS:NASDAQ

RT Quote | NASDAQ | USD
Last | 09/23/22 EDT
2.64quote price arrow down-0.08 (-2.94%)
Volume
543,659
52 week range
1.71 - 14.42
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.64
  • 52 Week High14.42
  • 52 Week High Date12/20/21
  • 52 Week Low1.71
  • 52 Week Low Date05/26/22

Key Stats

  • Market Cap192.75M
  • Shares Out73.01M
  • 10 Day Average Volume0.68M
  • Dividend-
  • Dividend Yield-
  • Beta0.49
  • YTD % Change-79.47

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.64
  • 52 Week High14.42
  • 52 Week High Date12/20/21
  • 52 Week Low1.71
  • 52 Week Low Date05/26/22
  • Market Cap192.75M
  • Shares Out73.01M
  • 10 Day Average Volume0.68M
  • Dividend-
  • Dividend Yield-
  • Beta0.49
  • YTD % Change-79.47

RATIOS/PROFITABILITY

  • EPS (TTM)-1.42
  • P/E (TTM)-1.87
  • Fwd P/E (NTM)-1.51
  • EBITDA (TTM)-110.319M
  • ROE (TTM)-67.98%
  • Revenue (TTM)18.34M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-634.23%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/01/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Gritstone bio Inc

 

Profile

MORE
Gritstone bio, Inc. is a biotechnology company. The Company discover, develop, manufacture and deliver next generation cancer and infectious disease immunotherapy candidates by vaccine vectors, self-amplifying mRNA (samRNA) and chimpanzee adenovirus (ChAd). Its two oncology programs in clinical-stage development are GRANITE, individualized neoantigen-based immunotherapy, and SLATE, an off-the-shelf shared neoantigen-based immunotherapy. The Company has an infectious disease...
Elaine Jones Ph.D.
Independent Chairman of the Board
Andrew Allen M.D., Ph.D.
President, Chief Executive Officer, Director
Erin Jones
Chief Operating Officer, Executive Vice President
Vassiliki Economides
Chief Financial Officer, Executive Vice President
Vijay Yabannavar Ph.D.
Executive Vice President, Chief Technical Development Officer
Address
5959 HORTON STREET, SUITE 300
Emeryville, CA
94608
United States

Top Peers

SYMBOLLASTCHG%CHG
LCTX
Lineage Cell Therapeutics Inc
1.18UNCHUNCH
KMPH
KemPharm Inc
5.83-0.12-2.02%
RPID
Rapid Micro Biosystems Inc
3.49+0.13+3.87%
ARMP
Armata Pharmaceuticals Inc
4.92+0.02+0.41%
PSTX
Poseida Therapeutics Inc
3.02-0.09-2.89%